DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
EMA.
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets.
Accessed March 18, 2021 at:
https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.